Arcadia Biosciences, Inc. · NASDAQ:RKDA
Arcadia Biosciences — Q2 2015 Earnings Presentation
9 slides from Arcadia Biosciences's earnings presentation, Aug 10, 2015
Slide 1: Second-Quarter 2015 Business Results
Second-Quarter 2015 Business Results August 10, 2015
Slide 2: Forward-looking statements
Forward-looking statements “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements about the company and its products, including statements relating to components of the company’s long-term financial success; the compa
Slide 3: Key financial results
Key financial results Second Quarter First Half % Increase/ % Increase/ 2015 2014 (Decrease) 2015 2014 (Decrease) Total revenues 1,430 1,305 10% 2,245 2,682 (16%) Cost of product revenues 106 46 130% 162 137 18% R&D expense 2,086 2,275 (8%) 3,918 4,258 (8%) SG&A expense 2,785 3,983 (30%) 5,423 5,867
Slide 4: Revenue
Revenue Second Quarter First Half % Increase/ % Increase/ 2015 2014 (Decrease) 2015 2014 (Decrease) Product revenue 179 65 175% 260 199 31% License revenue 401 195 106% 559 371 51% Contract research and 850 1,045 (19%) 1,426 2,112 (32%) governmental grants Total revenues 1,430 1,305 10% 2,245 2,682
Slide 5: Operating expenses
Operating expenses Second Quarter First Half % Increase/ % Increase/ 2015 2014 (Decrease) 2015 2014 (Decrease) Cost of product revenues 106 46 130% 162 137 18% R&D expense 2,086 2,275 (8%) 3,918 4,258 (8%) SG&A expense 2,785 3,983 (30%) 5,423 5,867 (8%) Total operating expenses 4,977 6,304 (21%) 9,5
Slide 6: Late-stage portfolio with 13 products in Phase 3 of development or later
Late-stage portfolio with 13 products in Phase 3 of development or later Phase D 1 2 3 4 C Program Crop Collaborator(s) Months 24-48 12-24 12-24 12-24 12-36 Key markets Productivity traits: Designed to increase crop yields and income through improved input efficiency and environmental stress toleran
Slide 7: Regulatory approvals and commercial partnerships continue to advance pipeline
Regulatory approvals and commercial partnerships continue to advance pipeline Regulatory advancements Commercial advancements Verdeca collaboration with TMG to advance Regulatory approval of stress-tolerant breeding of stress-tolerant soybeans in South soybeans by CONABIA in Argentina America Verdec
Slide 8: NUE rice demonstrates average yield increase of 27%
NUE rice demonstrates average yield increase of 27% Nitrogen Use Efficiency – Rice Market Channel Data Notes DEVELOPMENT PHASE /SUCCESS PROBABILITY • Major seed company • NEW: Fourth year of independent D 1 2 3 4 C in India; partially field testing demonstrated average 24-48 mo 12-24 mo 12-24 mo 12-
Slide 9: Open architecture maximizes technology access and global market penetration
Open architecture maximizes technology access and global market penetration Public Institutions Arcadia Licensees Gene Proof of Transform Field trial Transform Product Regulatory Seed Activities discovery concept into crops data into target development approval marketing crops and sales Rice Wheat B